John Barlow has sat on advisory board panels and received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Mylan, Novartis and Sanofi/Aventis
& Hacohen, N
Endocrinologia Japonica 17 , 2335 (1970)
Who Can Benefit from GLP-1s
The clinical presentation is a brown to brown-black macular lesion, predominantly solitary, encountered in the younger age group with a distinct female predilection [3, 12]
Moreover, depression is characterized by high prevalence of coexistence with many metabolic diseases, such as type 2 diabetes mellitus (T2DM) and obesity, and brain insulin resistance observed in both of these diseases is currently considered an important factor which may lead to the manifestation of depressive symptoms [10, 11]